Oaktree Acquisition Corp. III Life Sciences Unit (OACCU) is a special purpose acquisition company (SPAC) that focuses on identifying and merging with transformative companies in the life sciences sector. Leveraging a robust management team with deep industry expertise, OACCU aims to tackle significant healthcare challenges by investing in areas such as pharmaceuticals, biotechnology, and medical technology. As the life sciences field continues to evolve rapidly, OACCU is strategically positioned to create value for shareholders through investments that drive innovation, improve patient outcomes, and enhance overall health management solutions.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | -0.38% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.28 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 115.20% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $18.37M |
| % Insiders | 3.04% |
| % Institutions | 15.14% |
Volatility is currently contracting